Viewing Study NCT01534403


Ignite Creation Date: 2025-12-24 @ 7:36 PM
Ignite Modification Date: 2026-01-26 @ 6:12 AM
Study NCT ID: NCT01534403
Status: COMPLETED
Last Update Posted: 2016-05-06
First Post: 2012-02-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Open Label Extension Study of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE) Subjects
Sponsor: UCB Pharma
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Systemic Lupus Erythematosus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lupus View
None Monoclonal antibody View
None B-cell immunotherapy View
None Epratuzumab View